IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis

(1) Background: To date, the response of patients with rheumatoid arthritis (RA) to the various biologic DMARD available cannot be predicted due to a lack of reliable biomarkers. Based on our preliminary work on tmTNF reverse signaling, we developed a whole-blood assay measuring tmTNF crosslinking-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Krasselt, Marco, Gruz, Natalya, Pierer, Matthias, Baerwald, Christoph, Wagner, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225532/
https://www.ncbi.nlm.nih.gov/pubmed/35743787
http://dx.doi.org/10.3390/jpm12061003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225532/
https://www.ncbi.nlm.nih.gov/pubmed/35743787
http://dx.doi.org/10.3390/jpm12061003

Ejemplares similares